Back to STATE STREET CORP STATE STREET CORP

RCUSRCUS
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in Arcus Biosciences, Inc.

STATE STREET CORP holds 6M shares of RCUS (Arcus Biosciences, Inc.), worth $185.9M as of 2026-Q2. The position was increased (+11.4% shares). RCUS represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$185.9M

Current Shares

6M

Total Value Change

+$104.9M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6M
+11.4%
$185.9M0.0%$30.83
34
2026-Q1
Increased
5.4M
+18.3%
$116.9M0.0%$22.43
35
2025-Q4
Increased
4.6M
+34.8%
$109.1M0.0%$23.23
39
2025-Q3
Decreased
3.4M
-6.5%
$46.2M0.0%$13.32
0
2025-Q2
Decreased
3.6M
-1.8%
$29.6M0.0%$7.95
0
2025-Q1
Increased
3.7M
+23.5%
$29M0.0%$8.17
35
2024-Q4
Decreased
3M
-0.6%
$44.6M0.0%$14.91
0
2024-Q3
Decreased
3M
-1.4%
$46M0.0%$15.41
0
2024-Q2
Decreased
3.1M
-37.7%
$46.5M0.0%$15.23
0
2024-Q1
Increased
4.9M
+15.7%
$92.6M0.0%$18.88
34
2023-Q4
New
4.2M
-
$81M0.0%$19.10
41

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used